{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:16:47Z","timestamp":1784740607126,"version":"3.55.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12265-022-10252-x","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T18:03:03Z","timestamp":1649872983000},"page":"456-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Leveraging Extracellular Non-coding RNAs to Diagnose and Treat Heart Diseases"],"prefix":"10.1007","volume":"15","author":[{"given":"Zhenyi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1800-2384","authenticated-orcid":false,"given":"Zhihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"10252_CR1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/CIRCRESAHA.117.310752","volume":"120","author":"F Jansen","year":"2017","unstructured":"Jansen, F., Nickenig, G., & Werner, N. (2017). Extracellular vesicles in cardiovascular disease: Potential applications in diagnosis, prognosis, and epidemiology. Circulation Research, 120, 1649\u20131657. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310752","journal-title":"Circulation Research"},{"key":"10252_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00281-011-0250-3","volume":"33","author":"TH Lee","year":"2011","unstructured":"Lee, T. H., et al. (2011). Microvesicles as mediators of intercellular communication in cancer\u2013The emerging science of cellular \u201cdebris.\u201d Semin Immunopathol, 33, 455\u2013467. https:\/\/doi.org\/10.1007\/s00281-011-0250-3","journal-title":"Semin Immunopathol"},{"key":"10252_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molcel.2014.08.020","volume":"56","author":"C Cossetti","year":"2014","unstructured":"Cossetti, C., et al. (2014). Extracellular vesicles from neural stem cells transfer IFN-gamma via Ifngr1 to activate Stat1 signaling in target cells. Molecular Cell, 56, 193\u2013204. https:\/\/doi.org\/10.1016\/j.molcel.2014.08.020","journal-title":"Molecular Cell"},{"key":"10252_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2015.04.026","volume":"364","author":"I Hazan-Halevy","year":"2015","unstructured":"Hazan-Halevy, I., et al. (2015). Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes. Cancer Letters, 364, 59\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2015.04.026","journal-title":"Cancer Letters"},{"key":"10252_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee, Y. S., & Dutta, A. (2009). MicroRNAs in cancer. Annual Review of Pathology: Mechanisms of Disease, 4, 199\u2013227. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092222","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10252_CR6","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo, M., et al. (2015). Biological properties of extracellular vesicles and their physiological functions. The Journal of Extracellular Vesicles, 4, 27066. https:\/\/doi.org\/10.3402\/jev.v4.27066","journal-title":"The Journal of Extracellular Vesicles"},{"key":"10252_CR7","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/cvr\/cvz203","volume":"115","author":"F Fasolo","year":"2019","unstructured":"Fasolo, F., Di Gregoli, K., Maegdefessel, L., & Johnson, J. L. (2019). Non-coding RNAs in cardiovascular cell biology and atherosclerosis. Cardiovascular Research, 115, 1732\u20131756. https:\/\/doi.org\/10.1093\/cvr\/cvz203","journal-title":"Cardiovascular Research"},{"key":"10252_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature03001","volume":"431","author":"International Human Genome Sequencing, C","year":"2004","unstructured":"International Human Genome Sequencing, C. (2004). Finishing the euchromatic sequence of the human genome. Nature, 431, 931\u2013945. https:\/\/doi.org\/10.1038\/nature03001","journal-title":"Nature"},{"key":"10252_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1126\/science.337.6099.1159","volume":"337","author":"E Pennisi","year":"2012","unstructured":"Pennisi, E. (2012). ENCODE project writes eulogy for junk DNA. Science, 337, 1159\u20131161. https:\/\/doi.org\/10.1126\/science.337.6099.1159","journal-title":"Science"},{"key":"10252_CR10","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","volume":"48","author":"NB Tsui","year":"2002","unstructured":"Tsui, N. B., Ng, E. K., & Lo, Y. M. (2002). Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clinical Chemistry, 48, 1647\u20131653.","journal-title":"Clinical Chemistry"},{"key":"10252_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","volume":"31","author":"GK Wang","year":"2010","unstructured":"Wang, G. K., et al. (2010). Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal, 31, 659\u2013666. https:\/\/doi.org\/10.1093\/eurheartj\/ehq013","journal-title":"European Heart Journal"},{"key":"10252_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/clinchem\/18.6.519","volume":"18","author":"RC Kamm","year":"1972","unstructured":"Kamm, R. C., & Smith, A. G. (1972). Nucleic acid concentrations in normal human plasma. Clinical Chemistry, 18, 519\u2013522. https:\/\/doi.org\/10.1093\/clinchem\/18.6.519","journal-title":"Clinical Chemistry"},{"key":"10252_CR13","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","volume":"68","author":"B Gyorgy","year":"2011","unstructured":"Gyorgy, B., et al. (2011). Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cellular and Molecular Life Sciences, 68, 2667\u20132688. https:\/\/doi.org\/10.1007\/s00018-011-0689-3","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10252_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/cvr\/cvr266","volume":"93","author":"A Zampetaki","year":"2012","unstructured":"Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S., & Mayr, M. (2012). Profiling of circulating microRNAs: From single biomarkers to re-wired networks. Cardiovascular Research, 93, 555\u2013562. https:\/\/doi.org\/10.1093\/cvr\/cvr266","journal-title":"Cardiovascular Research"},{"key":"10252_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang, H., et al. (2018). Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nature Cell Biology, 20, 332\u2013343. https:\/\/doi.org\/10.1038\/s41556-018-0040-4","journal-title":"Nature Cell Biology"},{"key":"10252_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.semcdb.2016.11.008","volume":"67","author":"WS Toh","year":"2017","unstructured":"Toh, W. S., Lai, R. C., Hui, J. H. P., & Lim, S. K. (2017). MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. Seminars in Cell & Developmental Biology, 67, 56\u201364. https:\/\/doi.org\/10.1016\/j.semcdb.2016.11.008","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10252_CR17","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog, J., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology, 10, 1470\u20131476. https:\/\/doi.org\/10.1038\/ncb1800","journal-title":"Nature Cell Biology"},{"key":"10252_CR18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.healun.2020.06.011","volume":"39","author":"C Castellani","year":"2020","unstructured":"Castellani, C., et al. (2020). Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant. Journal of Heart and Lung Transplantation, 39, 1136\u20131148. https:\/\/doi.org\/10.1016\/j.healun.2020.06.011","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10252_CR19","doi-asserted-by":"publisher","first-page":"9272","DOI":"10.1093\/nar\/gks658","volume":"40","author":"EN Nolte-\u2018t Hoen","year":"2012","unstructured":"Nolte-\u2018t Hoen, E. N., et al. (2012). Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res, 40, 9272\u20139285. https:\/\/doi.org\/10.1093\/nar\/gks658","journal-title":"Nucleic Acids Res"},{"key":"10252_CR20","unstructured":"Yang, Q., Diamond, M. P., & Al-Hendy, A. (2016). The emerging role of extracellular vesicle-derived miRNAs: Implication in cancer progression and stem cell related diseases. Journal of Clinical Epigenetics, 2,"},{"key":"10252_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2011-02-338004","volume":"119","author":"A Montecalvo","year":"2012","unstructured":"Montecalvo, A., et al. (2012). Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood, 119, 756\u2013766. https:\/\/doi.org\/10.1182\/blood-2011-02-338004","journal-title":"Blood"},{"key":"10252_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2441","volume":"14","author":"E Hergenreider","year":"2012","unstructured":"Hergenreider, E., et al. (2012). Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature Cell Biology, 14, 249\u2013256. https:\/\/doi.org\/10.1038\/ncb2441","journal-title":"Nature Cell Biology"},{"key":"10252_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00018-018-2940-7","volume":"76","author":"M Pu","year":"2019","unstructured":"Pu, M., et al. (2019). Regulatory network of miRNA on its target: Coordination between transcriptional and post-transcriptional regulation of gene expression. Cellular and Molecular Life Sciences, 76, 441\u2013451. https:\/\/doi.org\/10.1007\/s00018-018-2940-7","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10252_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.devcel.2019.01.004","volume":"48","author":"FJ Verweij","year":"2019","unstructured":"Verweij, F. J., et al. (2019). Live tracking of inter-organ communication by endogenous exosomes In Vivo. Developmental Cell, 48, 573\u2013589. https:\/\/doi.org\/10.1016\/j.devcel.2019.01.004","journal-title":"Developmental Cell"},{"key":"10252_CR25","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1038\/ncomms8321","volume":"6","author":"M Alexander","year":"2015","unstructured":"Alexander, M., et al. (2015). Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nature Communications, 6, 7321. https:\/\/doi.org\/10.1038\/ncomms8321","journal-title":"Nature Communications"},{"key":"10252_CR26","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1038\/ncomms9472","volume":"6","author":"DG Phinney","year":"2015","unstructured":"Phinney, D. G., et al. (2015). Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nature Communications, 6, 8472. https:\/\/doi.org\/10.1038\/ncomms9472","journal-title":"Nature Communications"},{"key":"10252_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1261\/rna.036319.112","volume":"19","author":"X Chen","year":"2013","unstructured":"Chen, X., Liang, H., Zhang, J., Zen, K., & Zhang, C. Y. (2013). microRNAs are ligands of Toll-like receptors. RNA, 19, 737\u2013739. https:\/\/doi.org\/10.1261\/rna.036319.112","journal-title":"RNA"},{"key":"10252_CR28","doi-asserted-by":"publisher","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","volume":"109","author":"M Fabbri","year":"2012","unstructured":"Fabbri, M., et al. (2012). MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. The Proceedings of the National Academy of Sciences, 109, E2110-2116. https:\/\/doi.org\/10.1073\/pnas.1209414109","journal-title":"The Proceedings of the National Academy of Sciences"},{"key":"10252_CR29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","volume":"51","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y., et al. (2013). Circular intronic long noncoding RNAs. Molecular Cell, 51, 792\u2013806. https:\/\/doi.org\/10.1016\/j.molcel.2013.08.017","journal-title":"Molecular Cell"},{"key":"10252_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li, Z., et al. (2015). Exon-intron circular RNAs regulate transcription in the nucleus. Nature Structural & Molecular Biology, 22, 256\u2013264. https:\/\/doi.org\/10.1038\/nsmb.2959","journal-title":"Nature Structural & Molecular Biology"},{"key":"10252_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/ejhf.801","volume":"19","author":"Y Devaux","year":"2017","unstructured":"Devaux, Y., et al. (2017). Circular RNAs in heart failure. European Journal of Heart Failure, 19, 701\u2013709. https:\/\/doi.org\/10.1002\/ejhf.801","journal-title":"European Journal of Heart Failure"},{"key":"10252_CR32","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1038\/emboj.2011.359","volume":"30","author":"TB Hansen","year":"2011","unstructured":"Hansen, T. B., et al. (2011). miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO Journal, 30, 4414\u20134422. https:\/\/doi.org\/10.1038\/emboj.2011.359","journal-title":"EMBO Journal"},{"key":"10252_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak, S., et al. (2013). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 495, 333\u2013338. https:\/\/doi.org\/10.1038\/nature11928","journal-title":"Nature"},{"key":"10252_CR34","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/circresaha.116.309568","volume":"119","author":"MA Khan","year":"2016","unstructured":"Khan, M. A., et al. (2016). RBM20 regulates circular RNA production from the titin gene. Circulation Research, 119, 996\u20131003. https:\/\/doi.org\/10.1161\/circresaha.116.309568","journal-title":"Circulation Research"},{"key":"10252_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011). A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell, 146, 353\u2013358. https:\/\/doi.org\/10.1016\/j.cell.2011.07.014","journal-title":"Cell"},{"key":"10252_CR36","doi-asserted-by":"publisher","unstructured":"Filippova, E. A., et al. (2021). Long noncoding RNA GAS5 in breast cancer: Epigenetic mechanisms and biological functions. International Journal of Molecular Sciences, 22,. https:\/\/doi.org\/10.3390\/ijms22136810","DOI":"10.3390\/ijms22136810"},{"key":"10252_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbrc.2017.09.036","volume":"494","author":"W Wei","year":"2017","unstructured":"Wei, W., Chen, Y., Gao, J., & Li, C. (2017). WITHDRAWN: The lncRNA-GAS5\/miR-23a\/Foxo3a axis regulates cardiac hypertrophy by Wnt\/\u03b2-catenin signal pathway. Biochemical and Biophysical Research Communications, 494, 424. https:\/\/doi.org\/10.1016\/j.bbrc.2017.09.036","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10252_CR38","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/cdd.2013.110","volume":"20","author":"Z Zhang","year":"2013","unstructured":"Zhang, Z., et al. (2013). Negative regulation of lncRNA GAS5 by miR-21. Cell Death and Differentiation, 20, 1558\u20131568. https:\/\/doi.org\/10.1038\/cdd.2013.110","journal-title":"Cell Death and Differentiation"},{"key":"10252_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","volume":"114","author":"S Sahoo","year":"2014","unstructured":"Sahoo, S., & Losordo, D. W. (2014). Exosomes and cardiac repair after myocardial infarction. Circulation Research, 114, 333\u2013344. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.300639","journal-title":"Circulation Research"},{"key":"10252_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/cvr\/cvu022","volume":"102","author":"JP Sluijter","year":"2014","unstructured":"Sluijter, J. P., Verhage, V., Deddens, J. C., van den Akker, F., & Doevendans, P. A. (2014). Microvesicles and exosomes for intracardiac communication. Cardiovascular Research, 102, 302\u2013311. https:\/\/doi.org\/10.1093\/cvr\/cvu022","journal-title":"Cardiovascular Research"},{"key":"10252_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/ahg.12188","volume":"81","author":"A Feldman","year":"2017","unstructured":"Feldman, A., et al. (2017). Analysis of circulating miR-1, miR-23a, and miR-26a in atrial fibrillation patients undergoing coronary bypass artery grafting surgery. Annals of Human Genetics, 81, 99\u2013105. https:\/\/doi.org\/10.1111\/ahg.12188","journal-title":"Annals of Human Genetics"},{"key":"10252_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ejcts\/ezw245","volume":"51","author":"L Harling","year":"2017","unstructured":"Harling, L., et al. (2017). Elevated serum microRNA 483\u20135p levels may predict patients at risk of post-operative atrial fibrillation. European Journal of Cardio-Thoracic Surgery, 51, 73\u201378. https:\/\/doi.org\/10.1093\/ejcts\/ezw245","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"key":"10252_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1152\/physiolgenomics.00139.2010","volume":"43","author":"J Xiao","year":"2011","unstructured":"Xiao, J., et al. (2011). MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiological Genomics, 43, 655\u2013664. https:\/\/doi.org\/10.1152\/physiolgenomics.00139.2010","journal-title":"Physiological Genomics"},{"key":"10252_CR44","first-page":"27","volume":"56","author":"E Bostjancic","year":"2010","unstructured":"Bostjancic, E., Zidar, N., Stajner, D., & Glavac, D. (2010). MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction. Folia Biologica (Praha), 56, 27\u201331.","journal-title":"Folia Biologica (Praha)"},{"key":"10252_CR45","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.3892\/etm.2019.7976","volume":"18","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Zou, J., Liu, X., & Zhang, Q. (2019). MicroRNA-138 attenuates myocardial ischemia reperfusion injury through inhibiting mitochondria-mediated apoptosis by targeting HIF1-alpha. Experimental and Therapeutic Medicine, 18, 3325\u20133332. https:\/\/doi.org\/10.3892\/etm.2019.7976","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10252_CR46","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2169\/internalmedicine.50.5129","volume":"50","author":"R Wang","year":"2011","unstructured":"Wang, R., Li, N., Zhang, Y., Ran, Y., & Pu, J. (2011). Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Internal Medicine, 50, 1789\u20131795. https:\/\/doi.org\/10.2169\/internalmedicine.50.5129","journal-title":"Internal Medicine"},{"key":"10252_CR47","doi-asserted-by":"publisher","unstructured":"Xue, Y., Fan, X., Yang, R., Jiao, Y., & Li, Y. (2020). miR-29b-3p inhibits post-infarct cardiac fibrosis by targeting FOS. Bioscience Reports, 40,. https:\/\/doi.org\/10.1042\/BSR20201227","DOI":"10.1042\/BSR20201227"},{"key":"10252_CR48","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1159\/000479995","volume":"42","author":"J Yuan","year":"2017","unstructured":"Yuan, J., et al. (2017). Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7. Cellular Physiology and Biochemistry, 42, 2207\u20132219. https:\/\/doi.org\/10.1159\/000479995","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10252_CR49","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5152\/AnatolJCardiol.2015.6603","volume":"16","author":"U Eryilmaz","year":"2016","unstructured":"Eryilmaz, U., et al. (2016). Circulating microRNAs in patients with ST-elevation myocardial infarction. Anatolian Journal of Cardiology, 16, 392\u2013396. https:\/\/doi.org\/10.5152\/AnatolJCardiol.2015.6603","journal-title":"Anatolian Journal of Cardiology"},{"key":"10252_CR50","doi-asserted-by":"publisher","first-page":"40342","DOI":"10.1038\/srep40342","volume":"7","author":"CM Tang","year":"2017","unstructured":"Tang, C. M., et al. (2017). CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts. Science and Reports, 7, 40342. https:\/\/doi.org\/10.1038\/srep40342","journal-title":"Science and Reports"},{"key":"10252_CR51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care, A., et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nature Medicine, 13, 613\u2013618. https:\/\/doi.org\/10.1038\/nm1582","journal-title":"Nature Medicine"},{"key":"10252_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077938","volume":"8","author":"D Li","year":"2013","unstructured":"Li, D., et al. (2013). Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PLoS ONE, 8, e77938. https:\/\/doi.org\/10.1371\/journal.pone.0077938","journal-title":"PLoS ONE"},{"key":"10252_CR53","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/cvr\/cvz130","volume":"115","author":"TB Lim","year":"2019","unstructured":"Lim, T. B., et al. (2019). Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy. Cardiovascular Research, 115, 1998\u20132007. https:\/\/doi.org\/10.1093\/cvr\/cvz130","journal-title":"Cardiovascular Research"},{"key":"10252_CR54","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI70577","volume":"124","author":"C Bang","year":"2014","unstructured":"Bang, C., et al. (2014). Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. The Journal of Clinical Investigation, 124, 2136\u20132146. https:\/\/doi.org\/10.1172\/JCI70577","journal-title":"The Journal of Clinical Investigation"},{"key":"10252_CR55","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1161\/CIRCULATIONAHA.112.001357","volume":"128","author":"S Heymans","year":"2013","unstructured":"Heymans, S., et al. (2013). Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation, 128, 1420\u20131432. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.001357","journal-title":"Circulation"},{"key":"10252_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89908","volume":"1","author":"X Fang","year":"2016","unstructured":"Fang, X., et al. (2016). Adipocyte-specific loss of PPARgamma attenuates cardiac hypertrophy. JCI Insight, 1, e89908. https:\/\/doi.org\/10.1172\/jci.insight.89908","journal-title":"JCI Insight"},{"key":"10252_CR57","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.amjcard.2013.11.060","volume":"113","author":"Y Goren","year":"2014","unstructured":"Goren, Y., et al. (2014). Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure. American Journal of Cardiology, 113, 976\u2013981. https:\/\/doi.org\/10.1016\/j.amjcard.2013.11.060","journal-title":"American Journal of Cardiology"},{"key":"10252_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1126\/science.1139089","volume":"316","author":"EV Rooij","year":"2007","unstructured":"Rooij, E. V., et al. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 316, 575\u2013579. https:\/\/doi.org\/10.1126\/science.1139089","journal-title":"Science"},{"key":"10252_CR59","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/HJH.0b013e32833a4922","volume":"28","author":"D Li","year":"2010","unstructured":"Li, D., et al. (2010). MicroRNA-125a\/b-5p inhibits endothelin-1 expression in vascular endothelial cells. Journal of Hypertension, 28, 1646\u20131654. https:\/\/doi.org\/10.1097\/HJH.0b013e32833a4922","journal-title":"Journal of Hypertension"},{"key":"10252_CR60","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1253\/circj.cj-10-0457","volume":"75","author":"Y Fukushima","year":"2011","unstructured":"Fukushima, Y., Nakanishi, M., Nonogi, H., Goto, Y., & Iwai, N. (2011). Assessment of plasma miRNAs in congestive heart failure. Circulation Journal, 75, 336\u2013340. https:\/\/doi.org\/10.1253\/circj.cj-10-0457","journal-title":"Circulation Journal"},{"key":"10252_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.omtn.2021.05.023","volume":"25","author":"MR Hosen","year":"2021","unstructured":"Hosen, M. R., et al. (2021). CAD increases the long noncoding RNA PUNISHER in small extracellular vesicles and regulates endothelial cell function via vesicular shuttling. Molecular Therapy Nucleic Acids, 25, 388\u2013405. https:\/\/doi.org\/10.1016\/j.omtn.2021.05.023","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"10252_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185406","volume":"12","author":"L Chen","year":"2017","unstructured":"Chen, L., et al. (2017). Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. PLoS ONE, 12, e0185406. https:\/\/doi.org\/10.1371\/journal.pone.0185406","journal-title":"PLoS ONE"},{"key":"10252_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138849","volume":"10","author":"NA Garcia","year":"2015","unstructured":"Garcia, N. A., Ontoria-Oviedo, I., Gonzalez-King, H., Diez-Juan, A., & Sepulveda, P. (2015). Glucose starvation in cardiomyocytes enhances exosome secretion and promotes angiogenesis in endothelial cells. PLoS ONE, 10, e0138849. https:\/\/doi.org\/10.1371\/journal.pone.0138849","journal-title":"PLoS ONE"},{"key":"10252_CR64","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger, V. L., et al. (2012). Heart disease and stroke statistics\u20132012 update: A report from the American Heart Association. Circulation, 125, e2\u2013e220. https:\/\/doi.org\/10.1161\/CIR.0b013e31823ac046","journal-title":"Circulation"},{"key":"10252_CR65","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1161\/CIRCULATIONAHA.113.007917","volume":"130","author":"SG Ong","year":"2014","unstructured":"Ong, S. G., et al. (2014). Cross talk of combined gene and cell therapy in ischemic heart disease: Role of exosomal microRNA transfer. Circulation, 130, S60-69. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.007917","journal-title":"Circulation"},{"key":"10252_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pharmthera.2012.07.005","volume":"136","author":"SG Ong","year":"2012","unstructured":"Ong, S. G., & Hausenloy, D. J. (2012). Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacology & Therapeutics, 136, 69\u201381. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.005","journal-title":"Pharmacology & Therapeutics"},{"key":"10252_CR67","doi-asserted-by":"publisher","first-page":"16052","DOI":"10.1038\/cddiscovery.2016.52","volume":"2","author":"T Le","year":"2016","unstructured":"Le, T., & Chong, J. (2016). Cardiac progenitor cells for heart repair. Cell Death Discov, 2, 16052. https:\/\/doi.org\/10.1038\/cddiscovery.2016.52","journal-title":"Cell Death Discov"},{"key":"10252_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1549-8719.2011.00154.x","volume":"19","author":"YC Chan","year":"2012","unstructured":"Chan, Y. C., Banerjee, J., Choi, S. Y., & Sen, C. K. (2012). miR-210: The master hypoxamir. Microcirculation, 19, 215\u2013223. https:\/\/doi.org\/10.1111\/j.1549-8719.2011.00154.x","journal-title":"Microcirculation"},{"key":"10252_CR69","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/CIRCRESAHA.111.251546","volume":"109","author":"R Katare","year":"2011","unstructured":"Katare, R., et al. (2011). Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circulation Research, 109, 894\u2013906. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.251546","journal-title":"Circulation Research"},{"key":"10252_CR70","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/cvr\/cvu167","volume":"103","author":"L Barile","year":"2014","unstructured":"Barile, L., et al. (2014). Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovascular Research, 103, 530\u2013541. https:\/\/doi.org\/10.1093\/cvr\/cvu167","journal-title":"Cardiovascular Research"},{"key":"10252_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cell.2007.03.030","volume":"129","author":"Y Zhao","year":"2007","unstructured":"Zhao, Y., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 129, 303\u2013317. https:\/\/doi.org\/10.1016\/j.cell.2007.03.030","journal-title":"Cell"},{"key":"10252_CR72","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1101\/gad.1738708","volume":"22","author":"N Liu","year":"2008","unstructured":"Liu, N., et al. (2008). microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes & Development, 22, 3242\u20133254. https:\/\/doi.org\/10.1101\/gad.1738708","journal-title":"Genes & Development"},{"key":"10252_CR73","doi-asserted-by":"publisher","first-page":"e3412","DOI":"10.1097\/MD.0000000000003412","volume":"95","author":"J Ke-Gang","year":"2016","unstructured":"Ke-Gang, J., et al. (2016). Evaluating diagnostic and prognostic value of plasma miRNA133a in acute chest pain patients undergoing coronary angiography. Medicine (Baltimore), 95, e3412. https:\/\/doi.org\/10.1097\/MD.0000000000003412","journal-title":"Medicine (Baltimore)"},{"key":"10252_CR74","first-page":"138","volume":"1","author":"H Zhu","year":"2011","unstructured":"Zhu, H., & Fan, G. C. (2011). Extracellular\/circulating microRNAs and their potential role in cardiovascular disease. American Journal of Cardiovascular Diseases, 1, 138\u2013149.","journal-title":"American Journal of Cardiovascular Diseases"},{"key":"10252_CR75","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/01.cir.102.11.1216","volume":"102","author":"AS Jaffe","year":"2000","unstructured":"Jaffe, A. S., et al. (2000). It\u2019s time for a change to a troponin standard. Circulation, 102, 1216\u20131220. https:\/\/doi.org\/10.1161\/01.cir.102.11.1216","journal-title":"Circulation"},{"key":"10252_CR76","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.exger.2015.10.011","volume":"72","author":"X Liu","year":"2015","unstructured":"Liu, X., et al. (2015). Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: An independent study of Han population. Experimental Gerontology, 72, 230\u2013238. https:\/\/doi.org\/10.1016\/j.exger.2015.10.011","journal-title":"Experimental Gerontology"},{"key":"10252_CR77","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","volume":"3","author":"MF Corsten","year":"2010","unstructured":"Corsten, M. F., et al. (2010). Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circulation. Cardiovascular Genetics, 3, 499\u2013506. https:\/\/doi.org\/10.1161\/CIRCGENETICS.110.957415","journal-title":"Circulation. Cardiovascular Genetics"},{"key":"10252_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.11.012","volume":"75","author":"A Hammerer-Lercher","year":"2020","unstructured":"Hammerer-Lercher, A., Namdar, M., & Vuilleumier, N. (2020). Emerging biomarkers for cardiac arrhythmias. Clinical Biochemistry, 75, 1\u20136. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.11.012","journal-title":"Clinical Biochemistry"},{"key":"10252_CR79","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-981-15-1671-9_17","volume":"1229","author":"F Sustr","year":"2020","unstructured":"Sustr, F., Starek, Z., Soucek, M., & Novak, J. (2020). Non-coding RNAs and cardiac arrhythmias. Advances in Experimental Medicine and Biology, 1229, 287\u2013300. https:\/\/doi.org\/10.1007\/978-981-15-1671-9_17","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10252_CR80","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-981-15-1671-9_18","volume":"1229","author":"JA Kleeberger","year":"2020","unstructured":"Kleeberger, J. A., Tomsits, P. J., Kaab, S., & Clauss, S. (2020). Non-coding RNA and cardiac electrophysiological disorders. Advances in Experimental Medicine and Biology, 1229, 301\u2013310. https:\/\/doi.org\/10.1007\/978-981-15-1671-9_18","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10252_CR81","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1161\/CIRCULATIONAHA.120.052009","volume":"143","author":"O Shaihov-Teper","year":"2021","unstructured":"Shaihov-Teper, O., et al. (2021). Extracellular vesicles from epicardial fat facilitate atrial fibrillation. Circulation, 143, 2475\u20132493. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052009","journal-title":"Circulation"},{"key":"10252_CR82","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.1111\/jcmm.16985","volume":"25","author":"Q Ye","year":"2021","unstructured":"Ye, Q., et al. (2021). MicroRNA-146b-5p promotes atrial fibrosis in atrial fibrillation by repressing TIMP4. Journal of Cellular and Molecular Medicine, 25, 10543\u201310553. https:\/\/doi.org\/10.1111\/jcmm.16985","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10252_CR83","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s11033-020-05347-0","volume":"47","author":"L Yao","year":"2020","unstructured":"Yao, L., Zhou, B., You, L., Hu, H., & Xie, R. (2020). LncRNA MIAT\/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis. Molecular Biology Reports, 47, 2605\u20132617. https:\/\/doi.org\/10.1007\/s11033-020-05347-0","journal-title":"Molecular Biology Reports"},{"key":"10252_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3296","volume":"23","author":"A Asila","year":"2021","unstructured":"Asila, A., Yang, X., Kaisaer, Y., & Ma, L. (2021). SNHG16\/miR-485-5p\/BMP7 axis modulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. The Journal of Gene Medicine, 23, e3296. https:\/\/doi.org\/10.1002\/jgm.3296","journal-title":"The Journal of Gene Medicine"},{"key":"10252_CR85","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.12659\/msm.896191","volume":"22","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y., Yuan, Y., & Qiu, C. (2016). Underexpression of CACNA1C caused by overexpression of microRNA-29a underlies the pathogenesis of atrial fibrillation. Medical Science Monitor, 22, 2175\u20132181. https:\/\/doi.org\/10.12659\/msm.896191","journal-title":"Medical Science Monitor"},{"key":"10252_CR86","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu, I., & Minamino, T. (2016). Physiological and pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 97, 245\u2013262. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.06.001","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10252_CR87","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.omtn.2018.05.013","volume":"12","author":"X Nie","year":"2018","unstructured":"Nie, X., et al. (2018). miR-217 promotes cardiac hypertrophy and dysfunction by targeting PTEN. Mol Ther Nucleic Acids, 12, 254\u2013266. https:\/\/doi.org\/10.1016\/j.omtn.2018.05.013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10252_CR88","doi-asserted-by":"crossref","unstructured":"Li, H., et al. (2015). Identification of cardiac-related circulating microRNA profile in human chronic heart failure. Oncotarget, 7,","DOI":"10.18632\/oncotarget.6631"},{"key":"10252_CR89","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.5966\/sctm.2015-0032","volume":"4","author":"B Cai","year":"2015","unstructured":"Cai, B., et al. (2015). Mesenchymal stem cells and cardiomyocytes interplay to prevent myocardial hypertrophy. Stem Cells Translational Medicine, 4, 1425\u20131435. https:\/\/doi.org\/10.5966\/sctm.2015-0032","journal-title":"Stem Cells Translational Medicine"},{"key":"10252_CR90","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.jacc.2015.09.010","volume":"66","author":"AA Kelkar","year":"2015","unstructured":"Kelkar, A. A., et al. (2015). Mechanisms contributing to the progression of ischemic and nonischemic dilated cardiomyopathy: Possible modulating effects of paracrine activities of stem cells. Journal of the American College of Cardiology, 66, 2038\u20132047. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.010","journal-title":"Journal of the American College of Cardiology"},{"key":"10252_CR91","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11626-020-00481-2","volume":"56","author":"F Chen","year":"2020","unstructured":"Chen, F., et al. (2020). Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling. In Vitro Cellular and Developmental Biology. Animal, 56, 567\u2013576. https:\/\/doi.org\/10.1007\/s11626-020-00481-2","journal-title":"In Vitro Cellular and Developmental Biology. Animal"},{"key":"10252_CR92","doi-asserted-by":"publisher","first-page":"13252","DOI":"10.1002\/jcp.27997","volume":"234","author":"S Zhang","year":"2019","unstructured":"Zhang, S., et al. (2019). miR-29a attenuates cardiac hypertrophy through inhibition of PPARdelta expression. Journal of Cellular Physiology, 234, 13252\u201313262. https:\/\/doi.org\/10.1002\/jcp.27997","journal-title":"Journal of Cellular Physiology"},{"key":"10252_CR93","doi-asserted-by":"publisher","first-page":"13252","DOI":"10.1002\/jcp.27997","volume":"234","author":"S Zhang","year":"2019","unstructured":"Zhang, S., et al. (2019). miR-29a attenuates cardiac hypertrophy through inhibition of PPAR\u03b4 expression. Journal of Cellular Physiology, 234, 13252\u201313262. https:\/\/doi.org\/10.1002\/jcp.27997","journal-title":"Journal of Cellular Physiology"},{"key":"10252_CR94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccl.2013.09.015","volume":"32","author":"FL Johnson","year":"2014","unstructured":"Johnson, F. L. (2014). Pathophysiology and etiology of heart failure. Cardiol Clin, 32, 9\u201319. https:\/\/doi.org\/10.1016\/j.ccl.2013.09.015 vii.","journal-title":"Cardiol Clin"},{"key":"10252_CR95","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1172\/JCI123135","volume":"129","author":"L Qiao","year":"2019","unstructured":"Qiao, L., et al. (2019). microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. The Journal of Clinical Investigation, 129, 2237\u20132250. https:\/\/doi.org\/10.1172\/JCI123135","journal-title":"The Journal of Clinical Investigation"},{"key":"10252_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1247\/csf.27.1","volume":"27","author":"N Kioka","year":"2002","unstructured":"Kioka, N., Ueda, K., & Amachi, T. (2002). Vinexin, CAP\/ponsin, ArgBP2: A novel adaptor protein family regulating cytoskeletal organization and signal transduction. Cell Structure and Function, 27, 1\u20137. https:\/\/doi.org\/10.1247\/csf.27.1","journal-title":"Cell Structure and Function"},{"key":"10252_CR97","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/circresaha.110.218735","volume":"107","author":"H Cheng","year":"2010","unstructured":"Cheng, H., et al. (2010). Loss of enigma homolog protein results in dilated cardiomyopathy. Circulation Research, 107, 348\u2013356. https:\/\/doi.org\/10.1161\/circresaha.110.218735","journal-title":"Circulation Research"},{"key":"10252_CR98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tcm.2015.05.008","volume":"26","author":"B Duygu","year":"2016","unstructured":"Duygu, B., de Windt, L. J., & de Costa Martins, P. A. (2016). Targeting microRNAs in heart failure. Trends in Cardiovascular Medicine, 26, 99\u2013110. https:\/\/doi.org\/10.1016\/j.tcm.2015.05.008","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10252_CR99","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1172\/JCI43604","volume":"120","author":"DM Patrick","year":"2010","unstructured":"Patrick, D. M., et al. (2010). Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. The Journal of Clinical Investigation, 120, 3912\u20133916. https:\/\/doi.org\/10.1172\/JCI43604","journal-title":"The Journal of Clinical Investigation"},{"key":"10252_CR100","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1159\/000489383","volume":"46","author":"T Wu","year":"2018","unstructured":"Wu, T., et al. (2018). Serum exosomal MiR-92b-5p as a potential biomarker for acute heart failure caused by dilated cardiomyopathy. Cellular Physiology and Biochemistry, 46, 1939\u20131950. https:\/\/doi.org\/10.1159\/000489383","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10252_CR101","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2217\/fca-2017-0108","volume":"14","author":"S Klenke","year":"2018","unstructured":"Klenke, S., et al. (2018). Circulating miR-192 is a prognostic marker in patients with ischemic cardiomyopathy. Future Cardiology, 14, 283\u2013289. https:\/\/doi.org\/10.2217\/fca-2017-0108","journal-title":"Future Cardiology"},{"key":"10252_CR102","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/CIRCRESAHA.113.301209","volume":"113","author":"S Matsumoto","year":"2013","unstructured":"Matsumoto, S., et al. (2013). Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circulation Research, 113, 322\u2013326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301209","journal-title":"Circulation Research"},{"key":"10252_CR103","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein, J., et al. (2013). MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. The Journal of Clinical Investigation, 123, 2143\u20132154. https:\/\/doi.org\/10.1172\/JCI64365","journal-title":"The Journal of Clinical Investigation"},{"key":"10252_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina, S., & Abel, E. D. (2010). Diabetic cardiomyopathy, causes and effects. Reviews in Endocrine & Metabolic Disorders, 11, 31\u201339. https:\/\/doi.org\/10.1007\/s11154-010-9131-7","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"10252_CR105","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","volume":"818","author":"K Renu","year":"2018","unstructured":"Renu, K., V G, A., P B, T. P., & Arunachalam, S. (2018). Molecular mechanism of doxorubicin-induced cardiomyopathy \u2013 An update. European Journal of Pharmacology, 818, 241\u2013253. https:\/\/doi.org\/10.1016\/j.ejphar.2017.10.043","journal-title":"European Journal of Pharmacology"},{"key":"10252_CR106","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.18632\/aging.103136","volume":"12","author":"W Xia","year":"2020","unstructured":"Xia, W., Chen, H., Xie, C., & Hou, M. (2020). Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a. Aging (Albany NY), 12, 8241\u20138260. https:\/\/doi.org\/10.18632\/aging.103136","journal-title":"Aging (Albany NY)"},{"key":"10252_CR107","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.118.034598","volume":"138","author":"E-M Rogg","year":"2018","unstructured":"Rogg, E.-M., et al. (2018). Analysis of cell type-specific effects of MicroRNA-92a provides novel insights into target regulation and mechanism of action. Circulation, 138, 2545\u20132558. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034598","journal-title":"Circulation"},{"key":"10252_CR108","first-page":"927","volume":"5","author":"M Rafieian-Kopaei","year":"2014","unstructured":"Rafieian-Kopaei, M., Setorki, M., Doudi, M., Baradaran, A., & Nasri, H. (2014). Atherosclerosis: Process, indicators, risk factors and new hopes. International Journal of Preventive Medicine, 5, 927\u2013946.","journal-title":"International Journal of Preventive Medicine"},{"key":"10252_CR109","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gene.2016.07.023","volume":"592","author":"L Chen","year":"2016","unstructured":"Chen, L., et al. (2016). Global transcriptomic study of atherosclerosis development in rats. Gene, 592, 43\u201348. https:\/\/doi.org\/10.1016\/j.gene.2016.07.023","journal-title":"Gene"},{"key":"10252_CR110","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cardiores.2005.04.007","volume":"67","author":"A Brill","year":"2005","unstructured":"Brill, A., Dashevsky, O., Rivo, J., Gozal, Y., & Varon, D. (2005). Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovascular Research, 67, 30\u201338. https:\/\/doi.org\/10.1016\/j.cardiores.2005.04.007","journal-title":"Cardiovascular Research"},{"key":"10252_CR111","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.amjmed.2018.03.032","volume":"131","author":"JN Cohn","year":"2018","unstructured":"Cohn, J. N. (2018). Cardiovascular disease progression: A target for therapy? The American Journal of Medicine, 131, 1170\u20131173. https:\/\/doi.org\/10.1016\/j.amjmed.2018.03.032","journal-title":"The American Journal of Medicine"},{"key":"10252_CR112","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/cdd.2017.61","volume":"24","author":"K Wang","year":"2017","unstructured":"Wang, K., et al. (2017). Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression. Cell Death and Differentiation, 24, 1111\u20131120. https:\/\/doi.org\/10.1038\/cdd.2017.61","journal-title":"Cell Death and Differentiation"},{"key":"10252_CR113","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001249","volume":"3","author":"F Jansen","year":"2014","unstructured":"Jansen, F., et al. (2014). MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. Journal of the American Heart Association, 3, e001249. https:\/\/doi.org\/10.1161\/JAHA.114.001249","journal-title":"Journal of the American Heart Association"},{"key":"10252_CR114","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/CIRCGENETICS.110.958975","volume":"4","author":"Y Kuwabara","year":"2011","unstructured":"Kuwabara, Y., et al. (2011). Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circulation. Cardiovascular Genetics, 4, 446\u2013454. https:\/\/doi.org\/10.1161\/CIRCGENETICS.110.958975","journal-title":"Circulation. Cardiovascular Genetics"},{"key":"10252_CR115","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4274\/balkanmedj.galenos.2020.2020.1.94","volume":"37","author":"HA Cakmak","year":"2020","unstructured":"Cakmak, H. A., & Demir, M. (2020). MicroRNA and cardiovascular diseases. Balkan Medical Journal, 37, 60\u201371. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2020.2020.1.94","journal-title":"Balkan Medical Journal"},{"key":"10252_CR116","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrcardio.2014.207","volume":"12","author":"RA Boon","year":"2015","unstructured":"Boon, R. A., & Dimmeler, S. (2015). MicroRNAs in myocardial infarction. Nature Reviews. Cardiology, 12, 135\u2013142. https:\/\/doi.org\/10.1038\/nrcardio.2014.207","journal-title":"Nature Reviews. Cardiology"},{"key":"10252_CR117","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1248\/bpb.b12-00578","volume":"36","author":"K Endo","year":"2013","unstructured":"Endo, K., et al. (2013). MicroRNA 210 as a biomarker for congestive heart failure. Biological &\/and Pharmaceutical Bulletin, 36, 48\u201354. https:\/\/doi.org\/10.1248\/bpb.b12-00578","journal-title":"Biological &\/and Pharmaceutical Bulletin"},{"key":"10252_CR118","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/cvr\/cvp232","volume":"84","author":"Y Lu","year":"2009","unstructured":"Lu, Y., et al. (2009). MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: A new mechanism for ischaemic cardioprotection. Cardiovascular Research, 84, 434\u2013441. https:\/\/doi.org\/10.1093\/cvr\/cvp232","journal-title":"Cardiovascular Research"},{"key":"10252_CR119","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","volume":"39","author":"W Poller","year":"2018","unstructured":"Poller, W., et al. (2018). Non-coding RNAs in cardiovascular diseases: Diagnostic and therapeutic perspectives. European Heart Journal, 39, 2704\u20132716. https:\/\/doi.org\/10.1093\/eurheartj\/ehx165","journal-title":"European Heart Journal"},{"key":"10252_CR120","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","volume":"136","author":"A Ventura","year":"2009","unstructured":"Ventura, A., & Jacks, T. (2009). MicroRNAs and cancer: Short RNAs go a long way. Cell, 136, 586\u2013591. https:\/\/doi.org\/10.1016\/j.cell.2009.02.005","journal-title":"Cell"},{"key":"10252_CR121","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/HYPERTENSIONAHA.121.17574","volume":"78","author":"H Wang","year":"2021","unstructured":"Wang, H., et al. (2021). Percutaneous intracoronary delivery of plasma extracellular vesicles protects the myocardium against ischemia-reperfusion injury in Canis. Hypertension, 78, 1541\u20131554. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17574","journal-title":"Hypertension"},{"key":"10252_CR122","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40169-018-0192-7","volume":"7","author":"RE Lane","year":"2018","unstructured":"Lane, R. E., Korbie, D., Hill, M. M., & Trau, M. (2018). Extracellular vesicles as circulating cancer biomarkers: Opportunities and challenges. Clinical and Translational Medicine, 7, 14. https:\/\/doi.org\/10.1186\/s40169-018-0192-7","journal-title":"Clinical and Translational Medicine"},{"key":"10252_CR123","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymeth.2020.02.003","volume":"177","author":"A Yekula","year":"2020","unstructured":"Yekula, A., et al. (2020). From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers. Methods, 177, 58\u201366. https:\/\/doi.org\/10.1016\/j.ymeth.2020.02.003","journal-title":"Methods"},{"key":"10252_CR124","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008737","volume":"7","author":"X Wang","year":"2018","unstructured":"Wang, X., et al. (2018). Engineered exosomes with ischemic myocardium\u2010targeting peptide for targeted therapy in myocardial infarction. Journal of the American Heart Association, 7, e008737. https:\/\/doi.org\/10.1161\/JAHA.118.008737","journal-title":"Journal of the American Heart Association"},{"key":"10252_CR125","doi-asserted-by":"publisher","first-page":"10041","DOI":"10.1038\/s41598-019-46407-1","volume":"9","author":"KI Mentkowski","year":"2019","unstructured":"Mentkowski, K. I., & Lang, J. K. (2019). Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Science and Reports, 9, 10041. https:\/\/doi.org\/10.1038\/s41598-019-46407-1","journal-title":"Science and Reports"},{"key":"10252_CR126","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","volume":"499","author":"H Kim","year":"2018","unstructured":"Kim, H., et al. (2018). Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Biochemical and Biophysical Research Communications, 499, 803\u2013808. https:\/\/doi.org\/10.1016\/j.bbrc.2018.03.227","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10252_CR127","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41467-020-14957-y","volume":"11","author":"P Gee","year":"2020","unstructured":"Gee, P., et al. (2020). Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nature Communications, 11, 1334. https:\/\/doi.org\/10.1038\/s41467-020-14957-y","journal-title":"Nature Communications"},{"key":"10252_CR128","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ymthe.2018.10.002","volume":"27","author":"LA Campbell","year":"2019","unstructured":"Campbell, L. A., et al. (2019). Gesicle-mediated delivery of CRISPR\/Cas9 ribonucleoprotein complex for inactivating the HIV provirus. Molecular Therapy, 27, 151\u2013163. https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.002","journal-title":"Molecular Therapy"},{"key":"10252_CR129","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.7150\/thno.20576","volume":"8","author":"M Rodrigues","year":"2018","unstructured":"Rodrigues, M., Fan, J., Lyon, C., Wan, M., & Hu, Y. (2018). Role of extracellular vesicles in viral and bacterial infections: Pathogenesis, diagnostics, and therapeutics. Theranostics, 8, 2709\u20132721. https:\/\/doi.org\/10.7150\/thno.20576","journal-title":"Theranostics"},{"key":"10252_CR130","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1182\/bloodadvances.2017010181","volume":"1","author":"A Meliani","year":"2017","unstructured":"Meliani, A., et al. (2017). Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Advances, 1, 2019\u20132031. https:\/\/doi.org\/10.1182\/bloodadvances.2017010181","journal-title":"Blood Advances"},{"key":"10252_CR131","doi-asserted-by":"publisher","first-page":"9060","DOI":"10.3390\/ijms22169060","volume":"22","author":"Y Ju","year":"2021","unstructured":"Ju, Y., Bai, H., Ren, L., & Zhang, L. (2021). The role of exosome and the ESCRT pathway on enveloped virus infection. International Journal of Molecular Sciences, 22, 9060. https:\/\/doi.org\/10.3390\/ijms22169060","journal-title":"International Journal of Molecular Sciences"},{"key":"10252_CR132","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCRESAHA.111.253286","volume":"109","author":"S Sahoo","year":"2011","unstructured":"Sahoo, S., et al. (2011). Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circulation Research, 109, 724\u2013728. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.253286","journal-title":"Circulation Research"},{"key":"10252_CR133","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ymthe.2016.12.022","volume":"25","author":"C Beltrami","year":"2017","unstructured":"Beltrami, C., et al. (2017). Human pericardial fluid contains exosomes enriched with cardiovascular-expressed microRNAs and promotes therapeutic angiogenesis. Molecular Therapy, 25, 679\u2013693. https:\/\/doi.org\/10.1016\/j.ymthe.2016.12.022","journal-title":"Molecular Therapy"},{"key":"10252_CR134","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai, R. C., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Research, 4, 214\u2013222. https:\/\/doi.org\/10.1016\/j.scr.2009.12.003","journal-title":"Stem Cell Research"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-022-10252-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:34:26Z","timestamp":1655818466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-022-10252-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10252"],"URL":"https:\/\/doi.org\/10.1007\/s12265-022-10252-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}